Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs1376352 | chr7:33704994 | C/T | 1.18E-7 | 176 | 25.17 | 25.43 | 19.87 | KM Plot |
PCPG | rs137909390 | chr12:124078791 | C/A | 4.47E-5 | 176 | 25.87 | 19.87 | 20.13 | KM Plot |
PCPG | rs137919480 | chr2:24320649 | A/G | 0.000114 | 177 | 25.4 | 26.92 | 17.43 | KM Plot |
PCPG | rs137970130 | chr2:240712859 | C/A | 5.78E-9 | 172 | 26.92 | 23.83 | 6.25 | KM Plot |
PCPG | rs1380659 | chr2:107223010 | T/C | 0.000257 | 174 | 26.57 | 23.88 | 25.87 | KM Plot |
PCPG | rs138155346 | chr12:56672106 | T/A | 9.63E-8 | 178 | 25.35 | 27.33 | 0.8 | KM Plot |
PCPG | rs138159896 | chr7:105164522 | G/A | 5.12E-5 | 178 | 20.2 | 29.43 | 2.28 | KM Plot |
PCPG | rs138185775 | chr7:105161684 | GGGGA/G | 5.57E-5 | 176 | 20.28 | 30.45 | 2.28 | KM Plot |
PCPG | rs138231311 | chr10:29853946 | T/TCTTG | 5.6E-11 | 176 | 25.67 | 17.52 | 10.3 | KM Plot |
PCPG | rs138372213 | chr16:90083699 | C/G | 1.14E-8 | 174 | 25.87 | 20.2 | 6.62 | KM Plot |
PCPG | rs138376836 | chr16:89943323 | C/T | 0.000194 | 174 | 25.87 | 20.17 | 36.37 | KM Plot |
PCPG | rs138413549 | chr3:136665508 | TTGGATGCAATGTGTAA/T | 0.000469 | 177 | 22.15 | 27.33 | 23.03 | KM Plot |
PCPG | rs13842 | chr12:6572561 | A/T | 0.000263 | 174 | 19.3 | 25.97 | 25.77 | KM Plot |
PCPG | rs138422788 | chr2:24322310 | C/T | 0.000122 | 175 | 25.4 | 27.52 | 17.43 | KM Plot |
PCPG | rs138462423 | chr2:24319433 | CA/C | 0.000114 | 177 | 25.4 | 26.92 | 17.43 | KM Plot |